|
Income Statement for
ICU Medical Inc.
(ICUI)
|
|
|
|
|
|
|
| Income
[+]
|
in Thousands of Dollars |
|
|
| Operating Revenue |
316,869 |
302,195 |
282,959 |
231,513 |
204,726 |
| Total Revenue |
316,869 |
302,195 |
282,959 |
231,513 |
204,726 |
| Adjustments to Revenue |
N/A |
- |
- |
- |
- |
| Cost of Revenue |
138,773 |
140,253 |
135,552 |
104,494 |
100,594 |
| Cost of Sales With Depreciation |
160,359 |
159,841 |
153,989 |
122,695 |
114,910 |
| Gross Margin |
156,510 |
161,942 |
147,407 |
127,019 |
104,132 |
| Gross Operating Profit |
156,510 |
161,942 |
147,407 |
127,019 |
104,132 |
|
| Selling/General/Admin Expense |
(84,604) |
(85,287) |
(76,636) |
(68,205) |
(53,611) |
| Research & Development |
(10,630) |
(8,588) |
(4,678) |
(2,645) |
(4,822) |
| Advertising |
- |
- |
- |
- |
- |
| EBITDA (Operating Income Before Depreciation) |
- |
68,067 |
66,093 |
56,169 |
45,699 |
| Depreciation & Amortization |
(21,586) |
(19,588) |
(18,437) |
(18,201) |
(14,316) |
| Depreciation, Unreconciled |
- |
- |
- |
- |
- |
| Amortization |
- |
- |
- |
- |
- |
| Amortization of Intangibles |
- |
- |
- |
- |
- |
| Operating Income |
58,691 |
48,479 |
47,656 |
37,968 |
31,383 |
| Operating Profit After Depreciation |
58,691 |
48,479 |
47,656 |
37,968 |
31,383 |
| Interest Income |
- |
- |
- |
- |
- |
| Earnings from Equity Interest |
- |
- |
- |
- |
- |
| Other Income, Net |
563 |
15,443 |
129 |
1,181 |
4,695 |
| Income, Acquired in Process R&D |
- |
- |
- |
- |
- |
| Income, Restructuring and M&A |
- |
- |
- |
- |
- |
| Other Special Charges |
- |
2,500 |
- |
- |
- |
| Total Income Before Interest Expense (EBIT) |
61,839 |
66,422 |
47,785 |
39,149 |
36,078 |
| Interest Expense |
N/A |
- |
- |
- |
- |
| Income Before Tax |
61,839 |
66,422 |
47,785 |
39,149 |
36,078 |
| Income Taxes |
(20,558) |
(21,753) |
(17,862) |
(12,592) |
(11,778) |
| Minority Interest |
- |
- |
- |
- |
- |
| Preferred Securities of Subsidiary Trust |
- |
- |
- |
- |
- |
| Other Special Charges |
61,839 |
66,422 |
47,785 |
39,149 |
36,078 |
| Net Income from Continuing Operations |
41,281 |
44,669 |
29,923 |
26,557 |
24,300 |
| Net Income from Discontinued Operations |
- |
- |
- |
- |
- |
| Net Income from Total Operations |
41,281 |
44,669 |
29,923 |
26,557 |
24,300 |
|
| Normalized Income |
41,281 |
42,169 |
29,923 |
26,557 |
24,300 |
| Extraordinary Income/Loss |
- |
- |
- |
- |
- |
| Special Income/Charges |
- |
2,500 |
- |
- |
- |
| Income from Cum. Effect of Acct Change |
- |
- |
- |
- |
- |
| Income from Tax Loss Carryforward |
- |
- |
- |
- |
- |
| Net Income Available for Common |
41,281 |
44,669 |
29,923 |
26,557 |
24,300 |
| Other Gains |
- |
- |
- |
- |
- |
| Total Net Income |
41,281 |
44,669 |
29,923 |
26,557 |
24,300 |
| Net Income Available for Common |
41,281 |
44,669 |
29,923 |
26,557 |
24,300 |
|
| Results
[+]
|
in Dollars (Preferred Dividends in Thousands) |
|
|
| Dividends Paid Per Share |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Preferred Dividends |
- |
- |
- |
- |
- |
| Basic EPS from Continuing Operations |
2.90 |
3.23 |
2.20 |
1.80 |
1.72 |
| Basic EPS from Discontinued Operations |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Extraordinary Income Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Cumulative Effect of Accounting Change |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Tax Loss Carryforward |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Other Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Total Net Income |
2.90 |
3.23 |
2.20 |
1.80 |
1.72 |
| Basic Normalized Net Income per Share |
2.90 |
3.05 |
2.20 |
1.80 |
1.72 |
| Basic EPS from Total Operations |
2.90 |
3.23 |
2.20 |
1.80 |
1.72 |
|
| Diluted EPS from Continuing Operations |
2.80 |
3.15 |
2.16 |
1.77 |
1.67 |
| Diluted EPS from Discontinued Operations |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Extraordinary Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Cumulative Effect of Accounting Change |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Tax Loss Carryforward |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Other Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Total Net Income |
2.80 |
3.15 |
2.16 |
1.77 |
1.67 |
| Diluted Normalized Net Income per Share |
2.80 |
2.97 |
2.16 |
1.77 |
1.67 |
| Excise Tax |
- |
- |
- |
- |
- |
| Diluted EPS from Total Operations |
2.80 |
3.15 |
2.16 |
1.77 |
1.67 |
|
|
|